Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Nephrology/Urology | Psychiatry/Psychology | Obstetrics/Gynecology | Endocrinology
Disease Category: Sexual Dysfunction

Trial Information

Hypoactive Sexual Desire Disorder in Surgically Menopausal Women

A medical research study is underway for women who are concerned about their decreased sexual desire.  For many women, decreased sexual desire is often an unfortunate consequence of menopause and can lead to feelings of unhappiness, concern and frustration and can impact a woman’s relationship with her partner.  Hypoactive Sexual Desire Disorder (HSDD) is the most common form of female dysfunction.  The condition is typically identified by decreased or absent sexual fantasies and desire for sex - and the exact cause is unknown. 

Compensation: Eligible patients will receive up to $450.00

Study Description: The purpose of this study is to assess the safety and efficacy of LibiGel applied daily for 6 months compared to placebo treatment of HSDD in healthy, surgically menopausal women taking estrogen.

Inclusion Criteria

• Woman 30 to 65 years of age
• Undergone hysterectomy and bilateral oophorectomy prior to natural menopause
• Taking estrogen therapy for at least 3 months
• In a stable relationship for at least 1 year that is secure and communicative

Additional inclusion and exclusion criteria apply and will be reviewed with you.

Nicole, Carolyn and Diane, Research Staff
Coastal Connecticut Research, LLC
342 Montauk Avenue
New London, CT 06320
Phone: 860-443-4567
Fax: 860-442-7270
EMail: ccrvolunteer@gmail.com

View Google Map

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.